Vasundhara Rasayans Limited

VRL6

INE406F01010

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:59 28/06/2024 pm IST			5-day change	1st Jan Change
237 ^INR	-2.03%		-4.22%	+20.00%

28/05	Vasundhara Rasayans Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
04/04	Vasundhara Rasayans Limited Announces Resignation of Ashish Kedia as Director	CI

Vasundhara Rasayans Limited Announces Resignation of Shakshi Sharma as Company Secretary & Compliance Officer

August 13, 2020 at 02:00 pm IST

Vasundhara Rasayans Limited announced the resignation of Shakshi Sharma as Company Secretary & Compliance Officer with effect from July 31, 2020.

Latest news about Vasundhara Rasayans Limited

Vasundhara Rasayans Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	28/05	CI
Vasundhara Rasayans Limited Announces Resignation of Ashish Kedia as Director	04/04	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	10/11	CI
Vasundhara Rasayans Limited Approves Dividend for the Financial Year Ended March 31, 2023	29/23/29	CI
Vasundhara Rasayans Limited Proposes Dividend for the Financial Year Ended March 31, 2023	21/23/21	CI
Vasundhara Rasayans Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14	CI
Vasundhara Rasayans Limited Announces Board Appointments	01/23/01	CI
Vasundhara Rasayans Limited Announces Dividend for the Financial Year Ended March 31, 2023	01/23/01	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/23/29	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	29/23/29	CI
Vasundhara Rasayans Limited Announces Resignation of Rajesh Kumar Jain as Independent Director	25/23/25	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/23/14	CI
Vasundhara Rasayans Limited Declares Dividend for the Financial Year Ended March 31, 2022	01/22/01	CI
Vasundhara Rasayans Restarts Operations at Unit in Maharashtra, India	23/22/23	MT
Vasundhara Rasayans Limited Proposes Dividend for the Financial Year Ended 31 March 2022	06/22/06	CI
Vasundhara Rasayans Limited Reports Earnings Results for the Full Year Ended March 31, 2022	06/22/06	CI
Vasundhara Rasayans Shuts Down Operations on State Pollution Control Board Order	05/22/05	MT
Vasundhara Rasayans Board Declares Dividend for Fiscal 2022	25/22/25	MT
Vasundhara Rasayans Limited Recommends the Dividend for the Financial Year Ended March 31, 2022	25/22/25	CI
Vasundhara Rasayans Limited Recommends Dividend for the Financial Year Ended 31 March 2022	17/22/17	CI
Vasundhara Rasayans Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12/22/12	CI
Vasundhara Rasayans' Net Profit Soars in Fiscal Q4	09/22/09	MT
Vasundhara Rasayans Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/21/12	CI
Vasundhara Rasayans Limited Approves Dividend for the Financial Year Ended March 31, 2021	01/21/01	CI

Chart Vasundhara Rasayans Limited

Duration

Period

More charts

Vasundhara Rasayans Limited is an India-based company. The Company is engaged in manufacturing and exporting of antacid therapeutic category of Active Pharma Ingredients (API). In addition to the API manufacturing the Company is also operating an API intermediate plant to handle organic products with its specialized Friedel Craft reaction facility. It offers a range of products under Antacid API, such as Aluminum Hydroxide Gel, Magnesium Hydroxide, Magaldrate (Aluminum Magnesium Hydroxide Sulphate), Magnesium Trisilicate, Magnesium Silicate, and Aluminum Phosphate. These products are offered in paste, powder, and micronized grade powder, which is used to make liquid antacid formulations in place of conventional paste form of the products. Its product for Lake Color consists of Aluminum Hydroxide Gel Low Heavy Lead Content. Its product offering other applications of water treatment and Aluminum Salts includes Aluminum Hydroxide Amorphous, Aluminum Sulphate, and Poly Aluminum Chloride.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
VASUNDHARA RASAYANS LIMITED	+20.00%	92.13L
ELI LILLY AND COMPANY	+55.95%	82TCr
NOVO NORDISK A/S	+43.36%	64TCr
JOHNSON & JOHNSON	-6.98%	35TCr
MERCK & CO., INC.	+19.08%	33TCr
ABBVIE INC.	+9.05%	30TCr
ASTRAZENECA PLC	+17.17%	24TCr
ROCHE HOLDING AG	+2.90%	23TCr
NOVARTIS AG	+13.44%	22TCr
AMGEN INC.	+8.91%	17TCr